lurbinectedin
Restricted to oncology in the outpatient setting. Insurance certification or PAP eligibility review required prior to treatment. May be administered as "patient own medication" through PAP.
Reviewed: April 2021
High Value Care Committee: May 2021 - Approved
Restricted to oncology in the outpatient setting. Insurance certification or PAP eligibility review required prior to treatment. May be administered as "patient own medication" through PAP.
Reviewed: April 2021
High Value Care Committee: May 2021 - Approved